BOTHELL, Wash., Nov. 15, 2011 /PRNewswire/ -- Cardiac Science Corporation, an Opto Circuits Group company and a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced today an agreement to provide 151 Powerheart® AED G3 Pro® units to the Hong Kong Department of Health (DH).
"This alliance demonstrates the trend we see across the globe: Governments are increasingly deploying AEDs in public buildings to save lives," said Dave Marver, Cardiac Science president and chief executive officer. "We are proud that the Hong Kong Department of Health has chosen Cardiac Science AEDs to combat sudden cardiac arrest (SCA)."
The units, which will be fully deployed by year's end, will be available for medical professionals in government medical clinics throughout the region. Pacific Medical Systems Limited, Cardiac Science's exclusive distribution partner in Hong Kong, worked closely with the DH to secure the agreement.
"We applaud Pacific Medical Systems Limited for this flagship agreement and recognize our partner's value in the region," added Marver.
"We are glad that the Hong Kong Department of Health is deploying AEDs to create heart safe environments for citizens of its city, and we are pleased to have an increased presence in the Asia-Pac region through our trusted distribution partner Pacific Medical Systems Limited. This order is one of our first large deployments in this region," said Vinod Ramnani, Chairman and Managing Director, Opto Circuits.
The Powerheart® AED G3 Pro is a fully equipped AED for medical professionals and features a color display, 3-lead ECG monitoring capability, and manual defibrillation override.
Learn more about the Powerheart® AED G3 Pro.
About Cardiac Science
Cardiac Science, an Opto Circuits (India) Group company, develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT
For information, contact (media) Anastasia Mironova email@example.com+1.425.402.2092 | (investors) firstname.lastname@example.org | +91.80.2852.8088 LOGO: http://www.cardiacscience.com/images/main_logo.gif
|SOURCE Cardiac Science Corporation|
Copyright©2010 PR Newswire.
All rights reserved